The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma.
Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Pamplona.
Bruno
B
Paiva
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Mauricio
M
Chandia
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Noemi
N
Puig
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Maria-Belen
MB
Vidriales
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Jose J
JJ
Perez
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Lucia
L
Lopez-Corral
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Enrique M
EM
Ocio
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Ramon
R
Garcia-Sanz
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Norma C
NC
Gutierrez
Hospital 12 de Octubre, Madrid, Spain.
Ana
A
Jimenez-Ubieto
Hospital 12 de Octubre, Madrid, Spain.
Juan-José
JJ
Lahuerta
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain.
Maria-Victoria
MV
Mateos
Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Pamplona sanmiguel@unav.es.
Jesús F
JF
San Miguel
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005434:Flow Cytometry / Q000379:methods*; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate; D014182:Transplantation, Autologous
MRD; flow cytometry; myeloma; relapse